COMP <GO>
ST vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Sensata Technologies Holding plc (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ST 4
— TMO 11
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: ST
LAST: $40.27 (-2.49%) • MKT CAP: $6.01B
options-implied-move
6.50%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
options-implied-move
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ST VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ST | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.30% | 41.00% | -11.70 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.70% | 9.30% | -5.60 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.8x | 30.4x | -8.60 | ST | /valuation <GO> |
| Free Cash Flow Yield | 7.57% | 2.40% | +5.17 | ST | /fcf-yield <GO> |
| Operating Margin | 6.40% | 17.40% | -11.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 0.80% | 15.10% | -14.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -5.80% | 3.90% | -9.70 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.17% | 0.24% | +0.93 | ST | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.27 | 4.50 | -2.23 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.50% | 6.70% | -0.20 | ST | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.9 | 59.1 | -16.28 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.94 | -0.07 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 36.3x | +103.70 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.01B | $262.22B | -$256.21B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ST REV | TMO REV | ST GROSS % | TMO GROSS % | ST FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.70B | $44.56B | 29.3% | 44.0% | $454.8M | $6.29B |
| FY 2024 | $3.93B | $42.88B | 29.4% | 44.0% | $374.5M | $7.27B |
| FY 2023 | $4.05B | $42.86B | 44.0% | 44.0% | $274.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ST // BETA 0.87
TMO // BETA 0.94